– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

Monoclonal antibody therapy involving four quick injections works “essentially” as well in helping patients recover from COVID-19 as the more cumbersome intravenous infusions, according to a recent ...

Hydration Room, a Southern California-based chain of IV and injection therapy clinics, opened a new location in Los Gatos as ...

Injectafer (ferric carboxymaltose) is a prescription drug that’s used to treat iron deficiency anemia. Injectafer comes as a liquid solution for intravenous (IV) injection or infusion. It’s always ...

Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen® Patent strengthens Niagen Bioscience’s intellectual ...

A research team has developed an intravenous (IV) needle that softens upon insertion, minimizing risk of damage to blood vessels and tissues. Once used, it remains soft even at room temperature, ...

The IV and injection formulations support the rapid and efficient delivery of Niagen. Outperforming NAD+ IV in the pilot clinical study, Niagen IV offered superior tolerability, a 75% shorter infusion ...